KaydedilenlerDerginizi ekleyin

Dergiler / Türk Onkoloji Dergisi / 2021 / Cilt: 36 - Sayı: 3

Organ Sparing Approach in Bilateral Testis Tumors: A Short Review of the Literature with a Featuring Case

Sinan SÖZEN
Serhat ÇETİN
Müge AKMANSU
Volkan DEMİRCAN
Sayfa
409–413
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Average age of presentation of mixed GCT is 30 years old.[7] Any combination of histological subtypes is formally possible, although admixture of embryonal carcinoma and teratoma is more frequent.[8]

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Dear Editor, Testicular cancer (TC) is very rare in clinical practice.
📊
Temel Bulgular & Veri:It represents only 1-2% of all cancers.[1] However, TC is the most common malignancy in men between 15 and 40 years old.[2] Race, cryptorchidism, genetics, maternal estrogen exposure, and previous TC are main known risk factors.[3,4] Western and Northern Europe populations have significantly high incidence for TC.[5] Pathological classification of TCs consists of germ cell tumors (GCT), stromal tumors, ITGCN, and others.
💡
Sonuç & Katkı:Average age of presentation of mixed GCT is 30 years old.[7] Any combination of histological subtypes is formally possible, although admixture of embryonal carcinoma and teratoma is more frequent.[8]
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Dear Editor, Testicular cancer (TC) is very rare in clinical practice. It represents only 1-2% of all cancers.[1] However, TC is the most common malignancy in men between 15 and 40 years old.[2] Race, cryptorchidism, genetics, maternal estrogen exposure, and previous TC are main known risk factors.[3,4] Western and Northern Europe populations have significantly high incidence for TC.[5] Pathological classification of TCs consists of germ cell tumors (GCT), stromal tumors, ITGCN, and others. More than 90% of TC has GCT histology.[6] GCT is divided into 2 main subgroups such as seminomas and non-seminomatous tumors. Non-seminomatous GCT has 5 subtypes such as embryonal carcinoma, yolk sac tumors, choriocarcinoma, teratoma, and mixed tumors. Our patient has mixed GCT histology. Average age of presentation of mixed GCT is 30 years old.[7] Any combination of histological subtypes is formally possible, although admixture of embryonal carcinoma and teratoma is more frequent.[8]

🔖

Bu Makaleye Atıf Yap

SÖZEN, S., ÇETİN, S., AKMANSU, M., DEMİRCAN, V. (2022). Organ Sparing Approach in Bilateral Testis Tumors: A Short Review of the Literature with a Featuring Case. Türk Onkoloji Dergisi, Cilt: 36 - Sayı: 3, 409–413. https://ajindex.com/articles/639104

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997;337(4):242
  2. Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA, et al. International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev 2010;19(5):1151–9
  3. Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: An overview. Int J Cancer 2005;116(3):331–9
  4. Shankar S, Davies S, Giller R, Krailo M, Davis M, Gardner K, et al. In utero exposure to female hormones and germ cell tumors in children. Cancer 2006;106(5):1169–77
  5. Park JS, Kim J, Elghiaty A, Ham WS. Recent global trends in testicular cancer incidence and mortality. Medicine (Baltimore) 2018;97(37):e12390
  6. Bahrami A, Ro JY, Ayala AG. An overview of testicular germ cell tumors. Arch Pathol Lab Med 2007;131(8):1267–80
  7. Konstantinos S, Panagiotis P, Georgios P, Galariotis N, Olympitis M, Moschouris H, et al. Mixed germ cell tumor of the testicle with ravdomuosarcomatous component: A case report. Cases J 2009;2:9299
  8. Mostofi FK, Sesterhenn IA. Pathology of germ cell tumors of testes. Prog Clin Biol Res 1985;203:1–34
  9. Keske M, Canda AE, Yalcin S, Kilicarslan A, Kibar Y, Tuygun C, et al. Is testis-sparing surgery safe in small testicular masses? Results of a multicentre study. Can Urol Assoc J 2017;11(3–4):E100–4
  10. Khan MJ, Bedi N, Rahimi MN, Kalsi J. Testis sparing surgery for small testicular masses and frozen section assessment. Cent European J Urol 2018;71(3):304–9
  11. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn- Cedermark G, Fizazi K, et al. Guidelines on testicular cancer: 2015 update. Eur Urol 2015;68(6):1054–68
  12. Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, Skakkebaek NE. Carcinoma in situ testis, the progenitor of testicular germ cell tumours: A clinical review. Ann Oncol 2005;16(6):863–8
  13. Heidenreich A, Weissbach L, Holtl W, Albers P, Kliesch S, Köhrmann KU, et al. Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 2001;166(6):2161–5
  14. Sivakumar R, Sivaraman PB, Mohan-Babu N, Jainul- Abideen MI, Kalliyappan P, Balasubramanian K. Radiation exposure impairs luteinizing hormone signal transduction and steroidogenesis in cultured human leydig cells. Toxicol Sci 2006;91(2):550–6
  15. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European germ cell cancer